Migraine clinic marketing: no-cure wording, warning signs, injections, devices and ads

People who search for a headache or migraine clinic have been living with pain that keeps coming back. They have tried pharmacy remedies, sat in waiting rooms and read forum threads, and they want one thing from your site: a sign that this clinic will take them seriously and has something real to offer. That makes the copy on a headache practice site powerful, and it makes overpromising easy. Marketing for this work succeeds when it explains what the clinic does, says honestly what treatment can and cannot do, and sends anyone with warning signs to emergency care before they ever book.

Two related topics have their own guides and are not repeated here. Practice-wide marketing for neurologists, including referrals and subspecialty pages, is covered in our neurology practice marketing guide, and procedure-based pain care is covered in our pain management clinic marketing guide. This guide covers what is specific to headache and migraine clinics.

Start from what the condition is

The National Institute of Neurological Disorders and Stroke page on migraine describes it as a health condition that is more than having a bad headache, with symptoms that differ from person to person and episodes that can last from hours to days. It also says there is currently no cure for migraine, but treatments can help manage symptoms. The MedlinePlus Medical Encyclopedia page on migraine says the same in its own words: there is no specific cure, and the goal is to treat symptoms right away and prevent them.

That one fact should shape your whole site. A headache clinic is selling diagnosis, a plan, follow-up and the chance of fewer or milder episodes. It is not selling an end to the condition. Pages that start from that point are easier to write, easier to defend and closer to what patients who have lived with migraine for years already know.

The NINDS page on headache is a useful map for service pages. It separates primary headache, which happens on its own, from secondary headache, which happens because of another medical condition, and it lists tension-type headache, migraine and cluster headache among the primary types. A clinic that treats more than migraine can build one page per headache type, each with plain symptoms, how the clinic evaluates it and what the plan involves, and each linking back to the NINDS description.

Claims to rewrite before they go live

Headache marketing invites a few phrases that read well and promise too much. Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices or services. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence. Read each headline against those rules and against the NINDS statement that migraine has no cure.

Phrases that need rewriting:

• “Cure your migraines” or “end migraines for good”. NINDS says there is currently no cure. Write “a plan to reduce how hard and how frequent your episodes are” instead, and only if your clinic offers that plan.
• “Migraine-free” or “pain-free” as a promise. No clinic can promise a patient a life without episodes.
• “Find the root cause of your headaches” as a promise. Evaluation looks for causes and patterns; a page can describe the evaluation without promising what it will find.
• “Works when nothing else has”. NINDS notes that not every preventive treatment works for every person, and that finding the right one may take time.
• Any figure for reduced headache days, success rates or patient satisfaction that you cannot trace to a published source or your own documented and reviewed data.
• “Natural” or “drug-free” relief stated as if it were proven for everyone. NINDS lists non-medicine approaches that some people find helpful, and says supplements marketed for migraine have not been thoroughly tested.

Wording that holds up describes the process. “We review your headache history, examine you, and build a plan for treating episodes when they start and, where it fits, preventing them” matches how NINDS describes diagnosis and treatment, and it gives a reader something concrete.

Put the warning signs first

A headache clinic site will be read by people whose headache needs an emergency room, not an appointment. The MedlinePlus headache page tells readers to call 911 or the local emergency number, or go to the nearest emergency room, for warning signs that include a headache that is the worst ever, a headache with slurred speech, vision changes, trouble moving the arms or legs, loss of balance, confusion or memory loss, a headache with fever, stiff neck, nausea and vomiting, and a headache that comes with a head injury. Its migraine page adds a headache that starts suddenly. The NINDS headache page lists signs to call or see a doctor right away, including a sudden, severe headache, a headache with weakness or loss of sensation in any part of the body, which could be a sign of a stroke, and a constant headache in someone who has not had headaches before, especially if they are over age 50.

Put a short version of these signs, with a link to the MedlinePlus page, on every page where a patient can book or send a message:

• The home page and each headache type page, above or beside the booking button.
• The online booking flow and the contact form, before the patient submits.
• The after-hours phone message and any chat or AI front desk script, which should tell the caller to hang up and call 911 when a warning sign is described.
• Patient portal messages and appointment reminders, if patients can reply with symptoms.
• Ad landing pages, which are where new visitors arrive first.

Keep the wording plain and do not soften it into marketing copy. A line such as “If you have the worst headache of your life, a headache that started suddenly, or a headache with weakness, confusion, trouble speaking or a stiff neck and fever, call 911 now. Do not book an appointment.” is clear. Have your medical director approve the final text and when it is shown.

Medication overuse, explained honestly

Rebound headaches are a topic patients search for, and a clinic can explain them well. The MedlinePlus headache page says rebound headaches, also called medicine overuse headaches, keep coming back and can come from overuse of pain medicines for other headaches, and it says people who take pain medicine more than three days a week on a regular basis can develop them. The NINDS headache page says regular overuse of headache medications can worsen headache attacks or cause new symptoms.

That is useful education, and it is easy to turn into fear. A page should not tell readers to stop their medicines, should not suggest that their current doctor caused the problem, and should not imply that only your clinic can fix it. Explain what the sources say, link to them, and invite readers to review their medicines with a clinician.

Injections and devices: describe them as FDA does

Headache clinics may offer injectable preventive treatments, nerve blocks, infusions or devices, and these pages carry the highest risk. Name the treatment type, who it may be appropriate for, what the visit involves, the known risks and what the patient should report afterward. Do not name drug or device brands on service pages, do not state doses, and do not describe results beyond what the product labeling and your sources support.

Drug pages need care about approved uses. The FDA page Understanding Unapproved Use of Approved Drugs “Off Label” explains that approved labeling lists the specific diseases and conditions a drug is approved to treat, that providers may prescribe a drug for an unapproved use when they judge it medically appropriate, and that for an unapproved use FDA has not determined the drug is safe and effective. A page that markets a treatment for a headache type outside its approved labeling should not suggest FDA backing for that use. NINDS lists one injectable treatment as a long-term option for chronic migraine, which it defines by the number of headache days per month; if you offer it, keep the page to the patient group NINDS and the labeling describe.

Clinics that also offer cosmetic injections should keep those services on separate pages with separate claims. A cosmetic page that mentions headache relief, or a headache page that mentions wrinkles, blurs two different uses with different labeling. Our med spa marketing ideas guide covers the cosmetic side.

Devices follow their own rule. Under 21 CFR 807.97, a finding of substantial equivalence after premarket notification does not denote official approval of the device, and any representation that creates an impression of official approval because of it is misleading and constitutes misbranding. Describe a device by the intended use in its FDA decision and do not call it FDA approved unless it was approved. NINDS also says more research is needed on how helpful surgery and neurostimulation are for headache conditions, so a page should not present them as settled answers. Our medical device marketing claims guide covers this in more detail.

Headache diaries, quizzes and tracking

NINDS recommends a headache journal and lists what to record after each headache, including time, intensity, sensitivity to light or sound, medicines taken, sleep, stress and food. A printable diary or a link to the NINDS guidance is a useful, honest resource for a clinic site. An online diary, quiz or symptom checker is different, because it collects health information from people who have not yet become patients.

Keep that data out of advertising and analytics tools unless you have checked what each tool receives and what your agreements with it cover. Our guide to tracking pixels on practice websites explains the risk, and a headache app or diary that is not part of a covered entity may fall under the FTC Health Breach Notification Rule. A quiz should end with “talk to a clinician” and the warning signs, never with a diagnosis.

Patient stories and reviews

Stories from patients whose episodes improved are persuasive, and they need two checks. Under 16 CFR 255.2, an advertisement that uses a consumer endorsement about a key attribute of a service is likely to be read as representing that the endorser’s experience is representative of what others can generally expect, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. And under 45 CFR 164.508, a covered entity needs a valid written authorization from the patient before using their health information for marketing.

In practice, get a signed authorization before you publish any story, let the patient review the final words, and add a plain line that results vary and that migraine has no cure. Do not reply to online reviews in a way that confirms someone is your patient.

Ads for headache and migraine services

Google limits how health ads can reach people. The Google Ads healthcare and medicines policy says Google restricts the use of prescription drug terms in ads, landing pages and keywords, so naming prescription treatments in a campaign may be limited or not allowed depending on the location. The restricted targeting policy for personalized advertising lists health among its sensitive interest categories, which means you cannot build audiences around a person’s migraine or headache condition. Keyword and location targeting with an honest landing page is the safer route, and our healthcare ad policy basics guide covers the wider policy.

Illustration: two ads for the same clinic

Illustration: an ad reads “Cure your migraines in one visit. New injections, FDA approved, migraine-free in weeks. Book today.” It promises a cure NINDS says does not exist, claims a result no clinic can promise, uses FDA approval as a selling point without saying for what, and leads to a page with no warning signs.

Illustration: a second ad for the same clinic reads “Headache and migraine care at [Practice name]. Evaluation, a treatment plan and follow-up with a [license type]. Severe or sudden headache? Call 911.” The landing page explains the evaluation, lists treatment types without brands or doses, links to NINDS and MedlinePlus, and shows the warning signs above the booking button.

Checklist before a headache clinic campaign goes live

• No page or ad says cure, migraine-free, pain-free or end your migraines.
• Warning signs and the 911 line appear on the home page, booking flow, contact form, landing pages and after-hours scripts.
• Every treatment page names the treatment type, not a brand, with no doses and no result figures you cannot source.
• Drug pages stay within approved uses or say plainly when a use is unapproved, without implying FDA backing.
• Device pages match the FDA decision and do not say FDA approved unless the device was approved.
• Diaries, quizzes and forms do not send health details to ad or analytics tools.
• Each patient story has a signed authorization and a plain statement that results vary.
• Ads avoid prescription drug terms where Google restricts them and do not target by health condition.
• Each clinician is shown with their license type and exact title.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For a headache or migraine clinic, that means service pages that describe each headache type and treatment in plain words, warning signs placed where patients book, front desk scripts that route emergencies to 911, and inquiry forms that keep health details away from tracking tools. We do not decide clinical content, labeling questions or scope of practice; your medical director, your counsel and your state’s rules do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NINDS: Migraine (last reviewed August 10, 2026)
• NINDS: Headache (last reviewed March 13, 2026)
• MedlinePlus Medical Encyclopedia: Migraine (review date February 11, 2025)
• MedlinePlus Medical Encyclopedia: Headache (review date October 27, 2025)
• FDA: Understanding Unapproved Use of Approved Drugs “Off Label”
• 21 CFR 807.97: Misbranding by reference to premarket notification
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• Google Ads: Healthcare and medicines policy
• Google Ads: Restricted targeting in personalized advertising

More in Physician specialty marketing